Amplia Therapeutics and Australia New Zealand Gynaecological Oncology Group (Anzgog) Announce Ovarian Cancer Study
Go back to Amplia Therapeutics and Australia New Zealand Gynaecological Oncology Group (Anzgog) Announce Ovarian Cancer Study| COSTA-A (NASDAQ: ATX) | Delayed: 21.49 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $21.49 | 52 Week High | $22.62 | |||
| Open | $21.49 | 52 Week Low | $10.75 | |||
| Day High | $21.49 | P/E | 42.98 | |||
| Day Low | $21.49 | EPS | $0.50 | |||
| Volume | 47,094 | |||||
| (AMEX: INNMF) | Delayed: 0.08 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.08 | 52 Week High | $0.62 | |||
| Open | $0.08 | 52 Week Low | $0.12 | |||
| Day High | $0.08 | P/E | N/A | |||
| Day Low | $0.08 | EPS | $0.00 | |||
| Volume | 7,475 | |||||
